Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122147065 | 12214706 | 5 | F | 201512 | 20160819 | 20160328 | 20160825 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090217 | BRISTOL MYERS SQUIBB | 49.44 | YR | F | Y | 0.00000 | 20160825 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122147065 | 12214706 | 1 | PS | ABATACEPT | ABATACEPT | 1 | Intravenous (not otherwise specified) | 1000 MG, Q4WK | Y | AAD9543 | 125118 | 1000 | MG | SOLUTION FOR INFUSION | |||||
| 122147065 | 12214706 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 5 MG, QD | Y | 0 | 5 | MG | QD | ||||||
| 122147065 | 12214706 | 3 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 2.5 MG, QD | Y | 0 | 2.5 | MG | QD | ||||||
| 122147065 | 12214706 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 5 | C | OLMETEC PLUS | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 6 | C | ASAPHEN | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 7 | C | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 8 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 9 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 10 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 11 | C | SENNOSIDE /00571901/ | SENNOSIDES A AND B | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 12 | C | ATIVAN | LORAZEPAM | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 13 | C | M-ESLON | MORPHINE SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 14 | C | STATEX /00036302/ | MORPHINE SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 122147065 | 12214706 | 15 | C | CALCIUM + VITAMIN D /01483701/ | CALCIUMVITAMIN D | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122147065 | 12214706 | 1 | Rheumatoid arthritis |
| 122147065 | 12214706 | 2 | Product used for unknown indication |
| 122147065 | 12214706 | 4 | Product used for unknown indication |
| 122147065 | 12214706 | 5 | Product used for unknown indication |
| 122147065 | 12214706 | 6 | Product used for unknown indication |
| 122147065 | 12214706 | 7 | Product used for unknown indication |
| 122147065 | 12214706 | 8 | Product used for unknown indication |
| 122147065 | 12214706 | 9 | Product used for unknown indication |
| 122147065 | 12214706 | 10 | Product used for unknown indication |
| 122147065 | 12214706 | 11 | Product used for unknown indication |
| 122147065 | 12214706 | 12 | Product used for unknown indication |
| 122147065 | 12214706 | 13 | Product used for unknown indication |
| 122147065 | 12214706 | 14 | Product used for unknown indication |
| 122147065 | 12214706 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122147065 | 12214706 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122147065 | 12214706 | Appendicectomy | |
| 122147065 | 12214706 | Asthma | |
| 122147065 | 12214706 | Blood potassium decreased | |
| 122147065 | 12214706 | Bronchitis | |
| 122147065 | 12214706 | Cardiac disorder | |
| 122147065 | 12214706 | Cyst | |
| 122147065 | 12214706 | Diabetes mellitus | |
| 122147065 | 12214706 | Dyspnoea | |
| 122147065 | 12214706 | Fatigue | |
| 122147065 | 12214706 | Fluid retention | |
| 122147065 | 12214706 | Headache | |
| 122147065 | 12214706 | Nausea | |
| 122147065 | 12214706 | Oropharyngeal plaque | |
| 122147065 | 12214706 | Peripheral swelling | |
| 122147065 | 12214706 | Pneumonia | |
| 122147065 | 12214706 | Somnolence | |
| 122147065 | 12214706 | Vomiting | |
| 122147065 | 12214706 | Walking aid user |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122147065 | 12214706 | 1 | 20151207 | 0 |